[Chinese expert consensus on the use of standardized second-line drugs for primary hepatocellular carcinoma]. [PDF]
Translational Medicine Branch +5 more
europepmc +1 more source
[Guideline for the diagnosis and treatment of chronic myeloid leukemia in China (2025)]. [PDF]
Chinese Society of Hematology +1 more
europepmc +1 more source
[Study on the Inhibitory Effect and Mechanism of Trans-2-Decenal on <i>Helicobacter pylori</i> <i>in vitro</i>]. [PDF]
He L, He Q, Tian H, Fu Y, Cai L, Liao J.
europepmc +1 more source
[Safety of blinatumomab combined with dasatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia]. [PDF]
Zheng FY +5 more
europepmc +1 more source
[Identification of SORD as A Key Gene Mediating Osimertinib Primary Resistance in EGFR-Mutant Lung Adenocarcinoma via Machine Learning and Methylomics]. [PDF]
Liang G +8 more
europepmc +1 more source
[Advances in Lactate Metabolic Reprogramming in Non-small Cell Lung Cancer]. [PDF]
Zhou J, Ge L, Jiang J.
europepmc +1 more source
[SERPINE1 overexpression promotes proliferation and paclitaxel resistance of triple-negative breast cancer cells by inducing M2 macrophage polarization]. [PDF]
Zhang Q +10 more
europepmc +1 more source
[Molecular mechanisms and clinical applications of anti-angiogenic therapy in precision treatment of breast cancer]. [PDF]
Wang H, Jiang Y.
europepmc +1 more source
[<i>MUTYH-APEX1</i> Axis Promotes Hepatocellular Carcinoma Progression and Therapeutic Resistance by Regulating Cell Cycle Proteins]. [PDF]
Zhou Y +6 more
europepmc +1 more source
[A compulsory course in clinical treatment of burn patients: pain and analgesia]. [PDF]
Nie FF.
europepmc +1 more source

